China Resources Pharmaceutical Group Ltd.
3320
Rankning i aktier
#4273
China Resources Pharmaceutical Group Limited, an investment holding company,... China Resources Pharmaceutical Group Limited, an investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally. It operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. The company offers a range of chemical drugs, Chinese medicines, and biological drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular diseases, alimentary tract, endocrine diseases, respiratory diseases, orthopedics, nephrology, rheumatology and immunology, medical nutrition, pediatrics, genitourinary system, dermatological diseases, blood products, therapeutic infusions, antitumor drugs, medicine for cough and cold, anti-infection drugs, and psychoneurosis. It also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical/medical device manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, the company is involved in property holding activities, as well as operates retail pharmacies under the Teck Soon Hong brands. It distributes its products under the 999, Dong-E-E-Jiao, Double Crane, Zizhu, Jiangzhong, Boya, and Kun Zhong Yao to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
Aktiekurs
$0.58910029
Senast synkroniserad: 2026-10-16
Marknadsvärde
$3.70B
Förändring (1 dag)
-2.23%
Förändring (1 år)
-3.66%
Land
HK
Handel China Resources Pharmaceutical Group Ltd. (3320)
Kategori
Healthcare
Rörelsemarginal för China Resources Pharmaceutical Group Ltd. (3320)
Rörelsemarginal per October 2026 TTM: 4.21%
Enligt de senaste finansiella rapporterna och aktiekursen för China Resources Pharmaceutical Group Ltd. är företagets nuvarande rörelsemarginal (TTM) 4.21%. Vid slutet av 2023 var rörelsemarginalen 4.31%.
Historik för rörelsemarginal för China Resources Pharmaceutical Group Ltd. från 2013 till 2026
Rörelsemarginal vid slutet av varje år
| År | Rörelsemarginal | Ändra |
|---|---|---|
| 2026 (TTM) | 4.21% | -10.43% |
| 2024 | 4.70% | 9.05% |
| 2023 | 4.31% | 1.17% |
| 2022 | 4.26% | 8.95% |
| 2021 | 3.91% | -7.57% |
| 2020 | 4.23% | 7.91% |
| 2019 | 3.92% | -28.86% |
| 2018 | 5.51% | 2.42% |
| 2017 | 5.38% | 1.32% |
| 2016 | 5.31% | -1.30% |
| 2015 | 5.38% | -17.48% |
| 2014 | 6.52% | -10.44% |
| 2013 | 7.28% | 0.00% |
Rörelsemarginal för liknande företag eller konkurrenter
| Företag | Rörelsemarginal | Skillnad i rörelsemarginal | Land |
|---|---|---|---|
| 62.34% | -85.19% |
US
|
|
| 0.00% | - |
SE
|
|
| 0.00% | - |
FR
|
|
| 0.00% | - |
IT
|
|
| 0.77% | -99.82% |
US
|
Vad är ett företags Rörelsemarginal?
Rörelsemarginal är en viktig indikator för att bedöma ett företags lönsamhet. Högre Rörelsemarginals är generellt bättre eftersom de visar att ett företag kan sälja sina produkter eller tjänster för betydligt mer än produktionskostnaden. Rörelsemarginal beräknas genom att dividera företagets vinst med dess intäkter.